Cytosorbents
CTSO
#10844
Rank
NZ$26.21 M
Marketcap
NZ$8.32
Share price
2.52%
Change (1 day)
494.18%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -NZ$32.35 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$37.21 Million. In 2025 the company made an earning of -NZ$15.31 Million, an increase over its 2024 earnings that were of -NZ$40.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$32.35 Million111.36%
2025 -NZ$15.31 Million-62.16%
2024 -NZ$40.44 Million-22.49%
2023 -NZ$52.18 Million-13.52%
2022 -NZ$60.34 Million34.04%
2021 -NZ$45.02 Million182.17%
2020 -NZ$15.96 Million-55.97%
2019 -NZ$36.23 Million14.17%
2018 -NZ$31.73 Million95.14%
2017 -NZ$16.27 Million-22.32%
2016 -NZ$20.94 Million39.1%
2015 -NZ$15.05 Million-12.89%
2014 -NZ$17.28 Million89%
2013 -NZ$9.14 Million26.65%
2012 -NZ$7.22 Million-26.02%
2011 -NZ$9.76 Million-288.45%
2010 NZ$5.17 M-4.17%
2009 NZ$5.4 M-287.19%
2008 -NZ$2.89 Million-47.12%
2007 -NZ$5.46 Million41.78%
2006 -NZ$3.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$6.65 B-20,203.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.38 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
NZ$98.77 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA